(CNN) There are very few drugs that prevent people with early Covid-19 from progress to severe disease, but monoclonal antibodies may be among them. Less than two weeks later, the agency granted an EUA to Regeneron's monoclonal antibody cocktail, made up of two monoclonal antibodies, casirivimab and imdevimab, and called REGEN-COV2. According to the FDA, monoclonal antibodies should be given as soon as possible after symptoms emerge and a person tests positive for infection. It's important also to note that monoclonal antibodies don't appear to help -- and may actually harm -- people who are hospitalized. Access to a monoclonal antibodyThere are a couple of additional hurdles that need to be overcome to get monoclonal antibodies to people in time to help.

Source: CNN December 16, 2020 15:00 UTC